TY  - JOUR

T1  - Assessment of the benefits of bone modifying agents in the management of advanced breast, prostate, and lung cancers

JO  - Current Opinion in Supportive & Palliative Care

UR  - https://doi.org/10.1097/spc.0000000000000749

PY  - 2025/02/14

AU  - Leigh J

AU  - Lee SF

AU  - Fawaz A

AU  - Jia J

AU  - Theriau CF

AU  - Rodrigues J

AU  - Brown J

AU  - Ng TL

ED  - 

DO  - DOI: 10.1097/spc.0000000000000749

PB  - Ovid Technologies (Wolters Kluwer Health)

Y2  - 2025/02/28

ER  -